Holen Sie sich die Stockscreener-App
7.72
2.80%
0.21
Handel nachbörslich:
7.72
Schlusskurs vom Vortag:
$7.51
Offen:
$7.6
24-Stunden-Volumen:
197.15K
Relative Volume:
0.59
Marktkapitalisierung:
$201.89M
Einnahmen:
$47.26M
Nettoeinkommen (Verlust:
$-58.48M
KGV:
-2.8541
EPS:
-2.7049
Netto-Cashflow:
$-40.45M
1W Leistung:
+9.35%
1M Leistung:
+13.03%
6M Leistung:
-46.72%
1J Leistung:
-9.71%
1-Tages-Spanne:
$7.4461
$7.83
1-Wochen-Bereich:
$6.7875
$7.835
52-Wochen-Spanne:
$4.2993
$18.55
Cvrx Inc Stock (CVRX) Company Profile
Firmenname
Cvrx Inc
Sektor
Branche
Telefon
(763) 416-2850
Adresse
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Vergleichen Sie CVRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
7.72 | 195.81M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
129.40 | 228.63B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.25B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 144.00B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 118.82B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.89B | 5.69B | 4.14B | 577.90M | 6.96 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-09 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-01-14 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-11 | Bestätigt | Lake Street | Buy |
| 2024-05-01 | Fortgesetzt | Craig Hallum | Buy |
| 2024-05-01 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-01 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | Eingeleitet | Lake Street | Buy |
| 2022-07-18 | Eingeleitet | Craig Hallum | Buy |
| 2021-07-26 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-26 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-26 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cvrx Inc Aktie (CVRX) Neueste Nachrichten
How CVRx Inc. stock performs during market volatilityDouble Capital Strategy Picks - thegnnews.com
CVRx at Canaccord Genuity’s Conference: Strategic Shifts in Focus - Investing.com
Cantor Fitzgerald reiterates Overweight rating on CVRx stock amid growth By Investing.com - Investing.com Australia
Why CVRX stock attracts strong analyst attentionRisk-Reward Optimized Picks - thegnnews.com
Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Second-Quarter Report - simplywall.st
Earnings Update: CVRx, Inc. (NASDAQ:CVRX) Just Reported Its Second-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance
CVRx outlines $55M-$57M revenue target for 2025 as sales force transition nears completion - MSN
CVRx 2025 Q2 Earnings Slight Earnings Improvement Amid Sustained Losses - AInvest
CVRx, Inc. (NASDAQ:CVRX) Q2 2025 Earnings Call Transcript - Insider Monkey
CVRx Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Cvrx, Inc. Earnings Call Highlights Growth and Challenges - TipRanks
CVRx Appoints Brent Binkowski as New COO - The Globe and Mail
CVRx, Inc. shares fall 16.03% intraday after reporting wider-than-expected Q2 loss and lowering full-year revenue guidance. - AInvest
New Analyst Forecast: $CVRX Given 'Overweight' Rating - Quiver Quantitative
CVRx, Inc. SEC 10-Q Report - TradingView
CVRx revenue up 15% to USD 13.6M in Q2 2025 - Medical Buyer
CVRx Inc Reports 15% Revenue Growth, Expands Network, and Faces Challenges Amidst Strategic Expansion - AInvest
CVRx Inc (CVRX) Q2 2025 Earnings Call Highlights: Revenue Growth Amidst Strategic Expansion and ... By GuruFocus - Investing.com Canada
CVRx: Q2 Earnings Snapshot - Connecticut Post
CVRx, Inc. Reports Strong Q2 2025 Growth - TipRanks
CVRx Expects Q3 Revenue of $13.7M-$14.7M, Below Consensus of $14.54M. - AInvest
CVRx (CVRX) Q2 Revenue Jumps 15% - The Globe and Mail
CVRx Revenue Grows As Barostim Expansion Gains Momentum - Finimize
CVRx Grows Revenue And Expands Barostim Reach In Q2 - Finimize
CVRx Q2 2025 Earnings Call Transcript - MarketBeat
CVRx (CVRX) Reports Q2 Loss, Beats Revenue Estimates - sharewise.com
Earnings call transcript: CVRx Q2 2025 results show revenue growth By Investing.com - Investing.com Canada
Earnings call transcript: CVRx Q2 2025 results show revenue growth - Investing.com India
CVRx Inc. Q2 Earnings Report: Missed Expectations but Revenue Surpasses ForecastNews and Statistics - IndexBox
CVRx earnings missed by $0.05, revenue topped estimates - Investing.com Canada
CVRx Reports Second Quarter 2025 Financial and Operating Results - The Manila Times
Medical device maker CVRx beats Q2 revenue expectations - MarketScreener
CVRx, Inc. Reports 15% Revenue Growth in Q2 2025 and Announces New COO Appointment - Quiver Quantitative
CVRx Earnings: Heart Device Revenue Surges 15% with Medicare Payment Update for Barostim Technology - Stock Titan
When is CVRx Inc. stock expected to show significant growthFree Investment Community - Jammu Links News
How volatile is CVRx Inc. stock compared to the marketGet daily expert analysis for smarter investing - Jammu Links News
What is the dividend policy of CVRX stockTrack top-performing stocks in real-time - Jammu Links News
Is it the right time to buy CVRx Inc. stockBreakthrough capital growth - Jammu Links News
What makes CVRx Inc. stock price move sharplyUnstoppable investment returns - Jammu Links News
Why is CVRX stock attracting strong analyst attentionBuild wealth with reliable stock picks - Jammu Links News
What are the latest earnings results for CVRx Inc.Maximize your returns with portfolio optimization - Jammu Links News
What drives CVRX stock priceInvest confidently with data-driven strategies - Jammu Links News
What are CVRx Inc. company’s key revenue driversBuild a winning investment strategy - Jammu Links News
What institutional investors are buying CVRx Inc. stockPowerful profit generation - Jammu Links News
What are CVRX company’s key revenue driversExplosive earning power - Jammu Links News
How does CVRx Inc. compare to its industry peersHigh-octane investment opportunities await - Jammu Links News
What catalysts could drive CVRX stock higher in 2025Unlock expert stock analysis and alerts - Jammu Links News
How does CVRx Inc. generate profit in a changing economyTransform your portfolio with high-yield stocks - Jammu Links News
Finanzdaten der Cvrx Inc-Aktie (CVRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cvrx Inc-Aktie (CVRX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Nielsen Kirk G. | Director |
May 13 '25 |
Buy |
5.29 |
101,413 |
536,313 |
1,837,968 |
| Nielsen Kirk G. | Director |
May 14 '25 |
Buy |
5.23 |
61,200 |
320,364 |
1,899,168 |
| Nielsen Kirk G. | Director |
May 12 '25 |
Buy |
4.79 |
25,200 |
120,670 |
1,736,555 |
| Jain Mudit K. | Director |
May 12 '25 |
Buy |
4.66 |
1,500 |
6,986 |
4,900 |
| Jain Mudit K. | Director |
May 13 '25 |
Buy |
5.26 |
150 |
789 |
5,050 |
| Hykes Kevin | PRES & CEO |
May 12 '25 |
Buy |
4.84 |
5,000 |
24,200 |
133,000 |
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):